Correlation Between X4 Pharmaceuticals and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Tscan Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Tscan Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Tscan Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Tscan is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Tscan Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 3.17 times more return on investment than Tscan Therapeutics. However, X4 Pharmaceuticals is 3.17 times more volatile than Tscan Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 50.00 in X4 Pharmaceuticals on August 29, 2024 and sell it today you would lose (15.00) from holding X4 Pharmaceuticals or give up 30.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Tscan Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Tscan Therapeutics |
X4 Pharmaceuticals and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Tscan Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges |